Contra Verve Therapeutic - 925CVR011
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GAMMA Investing LLC | History | New | 257 | 0 | — | — | — | +257 | New | Q2 2026 | Jul 07, 2026 |
| Murphy & Mullick Capital Management Corp | History | Closed out | 0 | 0 | — | — | — | -43 | -100.0% | Q2 2026 | Aug 14, 2026 |
| Financial Gravity Companies, Inc. | History | New | 1 | 0 | — | — | — | +1 | New | Q2 2026 | Aug 05, 2026 |
| CIM INVESTMENT MANAGEMENT INC | History | No change | 27,072 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | May 19, 2026 |
| Financial Gravity Asset Management, Inc. | History | No change | 1 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | May 08, 2026 |